Specify a stock or a cryptocurrency in the search bar to get a summary
MeVis Medical Solutions AG
M3VMeVis Medical Solutions AG develops, markets, and sells software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company's clinical focuses are image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It offers X-ray based radiography procedures, including computed tomography, mammography/digital tomosynthesis, magnetic resonance imaging, and digital sonography; and provides services in the field of software programming for medical technology companies, which comprise provision of software developers, product and project managers, application specialists, and test engineers. The company also offers three-dimensional technical visualizations; and interactive online training to enhance the diagnostic skills of clinicians, as well as internet-based special applications in teleradiology. In addition, it develops and sells software licenses; and provides services for technical visualization and online training. The company was incorporated in 1997 and is based in Bremen, Germany. MeVis Medical Solutions AG is a subsidiary of Varex Imaging Deutschland AG. Address: Caroline-Herschel-Str. 1, Bremen, Germany, 28359
Analytics
WallStreet Target Price
–P/E ratio
7.6582Dividend Yield
4 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures M3V
Dividend Analytics M3V
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
28 %Dividend History M3V
Stock Valuation M3V
Financials M3V
Results | 2019 | Dynamics |